Urgent Investor Alert: Faruqi & Faruqi Investigates DENTSPLY SIRONA Lawsuit

Investor Alert: DENTSPLY SIRONA Investigated by Faruqi & Faruqi

Faruqi & Faruqi, LLP, a prominent national securities law firm, is rolling out an investigation into possible claims against DENTSPLY SIRONA Inc. This inquiry aims to address concerns surrounding the company's practices that may have misled investors and resulted in substantial financial losses.

Background of the Investigation

The announcement highlights a pressing deadline for affected investors seeking to take action. Specifically, those who incurred losses exceeding $75,000 between February 28, 2022, and November 6, 2024, are encouraged to take the next steps in advocating for their rights. With the deadline to seek the role of lead plaintiff in a federal securities class action coming up on January 27, 2025, time is of the essence.

Allegations Against DENTSPLY SIRONA

The investigation has emerged from serious allegations that DENTSPLY and its executives violated federal securities laws by making false or misleading statements. Key points of contention include:
1. Targeting Vulnerable Consumers: It is alleged that DENTSPLY targeted individuals lacking access to effective oral hygiene education and dental care. Many of these individuals had pre-existing dental issues that should have disqualified them from receiving treatment.
2. Sales Practices: The firm's promotional strategies reportedly pressured sales teams to enroll individuals who were not suitable for Byte aligners, increasing the risk of complications.
3. Inadequate Patient Safeguards: Claims suggest that the patient onboarding process failed to properly screen for contraindications, which could lead to serious injuries.
4. Failure to Report Injuries: The investigation points out that DENTSPLY was aware of rising reports concerning patient injuries for an extended period yet failed to notify regulatory authorities like the FDA.
5. Misrepresented Company Values: The allegations contend that DENTSPLY has materially overstated the goodwill value of its Byte segment, misleading investors regarding the company's performance and operational health.

Market Reactions and Financial Impact

The situation escalated dramatically when DENTSPLY disclosed the voluntary suspension of their Byte Aligners sales on October 24, 2024. They cited a review of regulatory requirements as the reason for this action, which was described as a precautionary measure. This announcement triggered a notable share price drop, decreasing over 4% in a single day.
Shortly thereafter, on November 7, 2024, DENTSPLY revealed details of a significant non-cash charge related to goodwill impairment, prompting another dramatic decline of around 28% in share value. The stock fell from $23.98 to $17.26 as investors reacted to the troubling news.

Next Steps for Investors

Faruqi & Faruqi is actively encouraging any individuals with relevant information about DENTSPLY's practices—including former employees, whistleblowers, and shareholders—to come forward. Legal avenues are available for members of the class who wish to pursue claims or share insights to support the investigation.

For further details on how to participate in the class action, claimants can reach out to Faruqi & Faruqi directly at their dedicated phone numbers for assistance.

Conclusion

As the January 27 deadline approaches, affected investors must consider their options quickly. This investigation may serve as a pivotal opportunity for DENTSPLY SIRONA investors to seek transparency and potential restitution for their financial setbacks. For continuous updates and more information, keeping in touch with Faruqi & Faruqi is advisable.

For further insights on the ongoing investigation and to verify your eligibility for participation, visit their official website or contact them directly.